id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-264607-5vnaifi6	Chen, Wenyu	A study on clinical effect of Arbidol combined with adjuvant therapy on COVID‐19	2020-06-08		.txt	text/plain	2520	137	53	OBJECTIVES: This study aims to explore the clinical effect of Arbidol (ARB) combined with adjuvant therapy on patients with coronavirus disease 2019 (COVID‐19). Various indexes in the two groups before and after treatment were observed and recorded, including fever, cough, hypodynamia, nasal obstruction, nasal discharge, diarrhea, C‐reactive protein (CRP), procalcitonin (PCT), blood routine indexes, blood biochemical indexes, time to achieve negative virus nucleic acid and so on. All clinical data of patients, including gender, hypertension, diabetes, CT, temperature, oxygen saturation, hemoglobin (HB) concentration, C-reactive protein (CRP) and so on, were listed in Table 1 Test group: ARB was additionally added on the basis of symptomatic treatment. Patient's clinical symptoms, such as fever, dry cough, nasal obstruction, nasal discharge, sore throat, hypodynamia, diarrhea, and some laboratory indexes including blood routine indexes, CRP, procalcitonin (PCT), blood biochemical indexes as well as the virus nucleic acid testing were observed and recorded during the treatment.	./cache/cord-264607-5vnaifi6.txt	./txt/cord-264607-5vnaifi6.txt